Shalini Sharp Insider Trading $ARRY ARRAY BIOPHARMA INC
Get free email notifications about insider trading for Shalini Sharp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shalini Sharp. Shalini Sharp is Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and CFO in AGENUS INC ($AGEN) and Director in AGENUS INC ($AGEN) and in ARRAY BIOPHARMA INC ($ARRY) and Director in ARRAY BIOPHARMA INC ($ARRY) and Director in SUTRO BIOPHARMA, INC. ($STRO) and CFO & Executive Vice President in Ultragenyx Pharmaceutical Inc. ($RARE) and CFO & Senior Vice President in Ultragenyx Pharmaceutical Inc. ($RARE) and EVP, Finance in Ultragenyx Pharmaceutical Inc. ($RARE) and in Mirati Therapeutics, Inc. ($MYG) and Director in Nuvation Bio Inc. ($PANA) and Director in Organon & Co. ($OGN).
Shalini Sharp in ARRAY BIOPHARMA INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Shalini Sharp: Director
Holdings: 5,000 shares
Current Value: $52,650
Latest Transaction: Jul 30 2019
$ARRY Market Capitalization: $1.80B
$ARRY Previous Close: $10.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Shalini Sharp in ARRAY BIOPHARMA INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGEN, ARRY, MYG, NBIX, NUVB, OGN, STRO, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Option Exercise | D | 8.70 | 25,000 | 217,500 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Director | Sell | D | 48.00 | 5,000 | 240,000 | 5,000 | 10 K to 5 K (-50.00 %) |
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | ||
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Option Exercise | A | 14.55 | 25,000 | 363,750 | 25,000 | ||
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Buy | M | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K | |
| Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
| Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | Sharp Shalini | Option Exercise | A | 10.47 | 25,000 | 261,750 | 25,000 |
Page: 1